John B Barnett
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$1.9MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $1.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 7, 2026 | NIH | SBIR Phase I Development of the novel small-molecule anti-osteoclastic drug ELP-004 to alleviate the symptoms of osteogenesis imperfecta (OI) | $172K | EXESALIBERO, INC. |
| Sep 1, 2021 | NIH | STTR Phase II Prevention of arthritis-induced bone erosion by inhibiting osteoclast differentiation by the haloanilide, N-Methyl Dichloropropionaniline | $395K | EXESALIBERO, INC. |
| Sep 22, 2020 | NIH | STTR Phase II Prevention of arthritis-induced bone erosion by inhibiting osteoclast differentiation by the haloanilide, N-Methyl Dichloropropionaniline | $1.1M | EXESALIBERO, INC. |
| Jan 21, 2020 | NIH | STTR Phase II Prevention of arthritis-induced bone erosion by inhibiting osteoclast differentiation by the haloanilide N-Methyl Dichloropropionaniline | $108K | EXESALIBERO, INC. |
| Sep 24, 2019 | NIH | STTR Phase II Prevention of arthritis-induced bone erosion by inhibiting osteoclast differentiation by the haloanilide, N-Methyl Dichloropropionaniline | $102K | EXESALIBERO, INC. |
Peer ranks
Federal funding#1,133
Awards as PI#417
Patents#273
Companies
- EXESALIBERO, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.